Nanocatalyst-Mediated Chemodynamic Tumor Therapy.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Traditional cancer therapies like chemotherapy and radiotherapy have limitations.
• Chemodynamic therapy (CDT) is a novel strategy using Fenton reactions to produce cytotoxic hydroxyl radicals (•OH) from hydrogen peroxide (H₂O₂).
• Current CDT faces challenges due to low catalytic efficiency and off-target effects.

Purpose of the Study:

• To review the development of chemodynamic therapy (CDT) for antitumor applications.
• To summarize recent advancements in nanocatalyst-mediated CDT.
• To discuss future trends and challenges in CDT.

Main Methods:

• Review of existing literature on chemodynamic therapy.
• Analysis of strategies to enhance CDT efficacy, including tumor microenvironment modification and nanocatalyst development.
• Focus on nanocatalyst-mediated CDT for anti-tumor applications.

Main Results:

• Nanocatalysts show promise in enhancing CDT efficiency.
• Strategies like optimizing the tumor microenvironment (increasing H₂O₂, decreasing reductants, lowering pH) can potentiate CDT.
• Overcoming limitations of the Fenton reaction is key for effective CDT.

Conclusions:

• Nanocatalyst-mediated CDT offers a promising avenue for cancer treatment.
• Further research is needed to optimize CDT strategies and address challenges for clinical translation.
• Future directions include developing more efficient nanocatalysts and targeted delivery systems.